Rate of PCV2 recombination not widely recognized
Sep 16, 2019Susan Spiegel
TOOLBOX, Issue 16: An interview with Meggan Bandrick, DVM, PhD Associate Director, Global Biologics Research, Zoetis
Evolution of PCV2 virus, need for broader coverage spurred development of Fostera® Gold PCV MH
Mar 01, 2019Susan Spiegel
DISCOVERIES, Issue 7: Compelling scientific evidence indicating the need for an updated porcine circovirus type 2 (PCV2) vaccine was the driving force behind the development of Fostera® Gold PCV...
New PCV2 vaccine for swine elicits strong cell-mediated immune response
Feb 28, 2019Susan Spiegel
DISCOVERIES, Issue 9: A new porcine circovirus type 2 (PCV2) vaccine from Zoetis produces a robust and lasting cell-mediated immune response.
Scientist ‘pops the hood’ on US pork industry’s newest vaccine for PCV2
Nov 28, 2018Susan Spiegel
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...
Part 1: Cell-mediated immunity critical to vaccine performance
Nov 28, 2018Susan Spiegel
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...
Part 2: Why two PCV2 genotypes are better than one
Nov 28, 2018Susan Spiegel
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...
Part 3: Chimeric vaccines combine strengths of each antigen to provide better coverage
Nov 28, 2018Susan Spiegel
What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with...
Epitope-comparison study illustrates broad coverage of Fostera Gold® PCV MH against PCV2 viruses
Aug 15, 2018Susan Spiegel
DISCOVERIES, Issue 4: Swine disease specialists speculated that a PCV2 vaccine containing two genotypes — PCV2a and PCV2b — would significantly improve the coverage provided against PCV2...
